42 related articles for article (PubMed ID: 23543443)
1. Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion.
Eiseler T; Döppler H; Yan IK; Goodison S; Storz P
Breast Cancer Res; 2009; 11(1):R13. PubMed ID: 19243594
[TBL] [Abstract][Full Text] [Related]
2. S100A4 Elevation Empowers Expression of Metastasis Effector Molecules in Human Breast Cancer.
Ismail TM; Bennett D; Platt-Higgins AM; Al-Medhity M; Barraclough R; Rudland PS
Cancer Res; 2017 Feb; 77(3):780-789. PubMed ID: 27927689
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature.
Köhrmann A; Kammerer U; Kapp M; Dietl J; Anacker J
BMC Cancer; 2009 Jun; 9():188. PubMed ID: 19531263
[TBL] [Abstract][Full Text] [Related]
4. Nuclear expression of S100A4 is associated with aggressive behavior of epithelial ovarian carcinoma: an important autocrine/paracrine factor in tumor progression.
Kikuchi N; Horiuchi A; Osada R; Imai T; Wang C; Chen X; Konishi I
Cancer Sci; 2006 Oct; 97(10):1061-9. PubMed ID: 16984379
[TBL] [Abstract][Full Text] [Related]
5. Matrix degradation and cell proliferation are coupled to promote invasion and escape from an engineered human breast microtumor.
Rabie EM; Zhang SX; Kourouklis AP; Kilinc AN; Simi AK; Radisky DC; Tien J; Nelson CM
Integr Biol (Camb); 2021 Feb; 13(1):17-29. PubMed ID: 33497442
[TBL] [Abstract][Full Text] [Related]
6. ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway.
Zhou X; Zhao J; Yan T; Ye D; Wang Y; Zhou B; Liu D; Wang X; Zheng W; Zheng B; Qian F; Li Y; Li D; Fang L
Cell Death Dis; 2024 Apr; 15(4):260. PubMed ID: 38609357
[TBL] [Abstract][Full Text] [Related]
7. [S100A4, a potential therapeutic target on bladder cancer stem cells].
Wang CY; Nie QW; Zhou X; Huang DX; Xiao WQ; Zhu YT
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Jul; 37(7):869-874. PubMed ID: 28736360
[TBL] [Abstract][Full Text] [Related]
8. Protective Effects of Relaxin 2 (RLXH2) against Hypoxia-Induced Oxidative Damage and Cell Death via Activation of The Nrf2/HO-1 Signalling Pathway in Gastric Cancer Cells.
Wang L; Zhou Y; Lin H; Hou K
Cell J; 2023 Sep; 25(9):625-632. PubMed ID: 37718765
[TBL] [Abstract][Full Text] [Related]
9. The dual and multifaceted role of relaxin-2 in cancer.
Kwantwi LB
Clin Transl Oncol; 2023 Oct; 25(10):2763-2771. PubMed ID: 36947362
[TBL] [Abstract][Full Text] [Related]
10. Novel lncRNAs with diagnostic or prognostic value screened out from breast cancer via bioinformatics analyses.
Wang H; Shu L; Niu N; Zhao C; Lu S; Li Y; Wang H; Liu Y; Zou T; Zou J; Wu X; Wang Y
PeerJ; 2022; 10():e13641. PubMed ID: 35855425
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound-Targeted Microbubble Destruction (UTMD) Combined with Liposome Increases the Effectiveness of Suppressing Proliferation, Migration, Invasion, and Epithelial- Mesenchymal Transition (EMT) via Targeting Metadherin (MTDH) by ShRNA.
Xu J; Wang Y; Li Z; Wang Q; Zhou X; Wu W
Med Sci Monit; 2019 Apr; 25():2640-2648. PubMed ID: 30969950
[TBL] [Abstract][Full Text] [Related]
12. Androgen-dependent alternative mRNA isoform expression in prostate cancer cells.
Munkley J; Maia TM; Ibarluzea N; Livermore KE; Vodak D; Ehrmann I; James K; Rajan P; Barbosa-Morais NL; Elliott DJ
F1000Res; 2018; 7():1189. PubMed ID: 30271587
[No Abstract] [Full Text] [Related]
13. Relaxin 2/RXFP1 Signaling Induces Cell Invasion via the β-Catenin Pathway in Endometrial Cancer.
Fue M; Miki Y; Takagi K; Hashimoto C; Yaegashi N; Suzuki T; Ito K
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126180
[TBL] [Abstract][Full Text] [Related]
14. In silico discovery of significant pathways in colorectal cancer metastasis using a two-stage optimisation approach.
Akutekwe A; Seker H; Yang S
IET Syst Biol; 2015 Dec; 9(6):294-302. PubMed ID: 26577164
[TBL] [Abstract][Full Text] [Related]
15. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by upregulation of S100A4/MMPs signaling.
Cao WH; Liu HM; Liu X; Li JG; Liang J; Liu M; Niu ZH
Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):609-17. PubMed ID: 23543443
[TBL] [Abstract][Full Text] [Related]
16. Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.
Radestock Y; Hoang-Vu C; Hombach-Klonisch S
Breast Cancer Res; 2008; 10(4):R71. PubMed ID: 18718015
[TBL] [Abstract][Full Text] [Related]
17. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases.
Binder C; Hagemann T; Husen B; Schulz M; Einspanier A
Mol Hum Reprod; 2002 Sep; 8(9):789-96. PubMed ID: 12200455
[TBL] [Abstract][Full Text] [Related]
18. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
Wang L; Wang X; Liang Y; Diao X; Chen Q
Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of matrix metalloproteinases and their tissue inhibitors by S100A4.
Elenjord R; Ljones H; Sundkvist E; Loennechen T; Winberg JO
Connect Tissue Res; 2008; 49(3):185-8. PubMed ID: 18661339
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
